Compound Screening TRIZ Cases

TGF-β and TSP-1 expression thresholds verify cell therapy efficacy before treatment, improving batch consistency and avoiding ineffective use.

EOSPD iPSC-derived midbrain neurons reveal PKC-α and lysosomal dysfunction, while PEP005 reduces α-synuclein buildup.

Cyclic pentapeptides with a cyclo-TXSXW motif inhibit misfolded SOD1 aggregation and neurotoxicity, improving cell viability in ALS-related cases.

A five-layer microfluidic chip enables in situ 3D printing, medium renewal, and cerebrospinal fluid-like perfusion for long-term cortical organoid culture.

Co-culture potency assays track marker expression and analyte secretion to improve TIL quality control while shortening closed-system expansion.

Blocking the dimer interface in vimentin or keratin filaments prevents tetramer formation and helps impede cancer metastasis.

Small molecules such as B7 block PRRSV binding to the CD163-SRCR5 receptor, reducing viral titers and supporting pig prophylaxis and treatment.

Measuring superoxide dismutase activity in biological samples enables earlier MCI detection and supports screening of therapeutic candidates.

Waste effluent biofluids are used in cell assays to mimic in vivo tumor conditions and improve therapeutic efficacy evaluation.

CTLA-4 treatment for dilated cardiomyopathy helps reduce cardiac fibrosis, restore lymphatic function, and rebalance harmful immune activity.

Measuring SOD activity with ESR provides an objective biomarker for early MCI detection and screening of candidate substances.

Blood-based PD-L1 assessment on circulating cancer cells enables non-invasive treatment selection and real-time monitoring for immune checkpoint therapy.

Objective SOD activity measurement in saliva or other biological samples improves early MCI screening and supports therapeutic candidate selection.

PGAM2-based screening improves breeding bull fertility by boosting Sertoli cell glycolysis, blood-testis barrier function, and spermatogenesis.

Targeting CITED2 interactions with CDK11bp58, SF3B1, and 14-3-3γ helps control cancer mitosis while limiting centrosome and spindle defects.

Blocking CKAP4 disrupts the Dkk1 pathway that drives tumor hyperproliferation, improving antitumor specificity and safety.

Patient-derived iPSC dopaminergic neurons reveal PKC-alpha-linked lysosomal dysfunction, enabling PEP005 to lower alpha-synuclein.

A screening and kinetic workflow identifies nonallosteric sirtuin activators that bind near the active site to improve catalysis across substrates.

Dual-labeled peptide-MHC sorting isolates target-specific CD8+ T cells without prior activation, cutting production time and cross-reactivity.

Blocking HopQ-CEACAM adhesion offers a non-antibiotic way to prevent or treat H. pylori infection while avoiding resistance and side effects.

Using 4-HMA as a metabolic intermediary helps raise CoQ10 biosynthesis in HPDL-related disorders without relying on uncertain CoQ10 absorption.

Blocking LFA-1 and ICAM-1 interactions helps control dry eye inflammation, improve tear production, and support longer-term symptom relief.

Macrocyclic peptides found through a bacterial screening platform inhibit SOD1 and Aβ aggregation, reducing neurotoxicity in misfolding diseases.

Targeting C5 with complement inhibitors such as zilucoplan helps limit muscle tissue destruction and improve strength in IMNM.

Bioluminescent succinate readout enables high-throughput C-P4H1 inhibitor screening, identifying Silodosin and Ticlopidine to curb collagen deposition.

Targeting PDH activity offers a safer way to prevent or treat chemotherapy-induced neuropathy while reducing symptoms and limiting side effects.

A standard-lab B cell assay uses TLR agonists and cytokines to drive plasma cell differentiation for accessible immunomodulator screening.

Patient-derived 3D hydrogel cultures preserve native tumor and immune cell function for real-time tracking of live interactions and therapy testing.

Targeted TMEM216 variant detection improves ciliopathy diagnosis by identifying causative polymorphisms linked to JS, JSRD, and MKS.

Targeting a PI3Kα-specific allosteric pocket avoids ATP-site off-target binding, lowers toxicity, and helps overcome mutation-driven resistance.

Combining cell-free translation with thiopeptide enzymes enables rapid production of diverse macrocyclized peptide libraries for binding screens.

A cleavable peptide carrier balances lipid and aqueous solubility to move therapeutic compounds into the cytosol while limiting endosomal entrapment.

Protein markers in aqueous humor enable earlier Alzheimer’s and Parkinson’s diagnosis without invasive brain biopsy.

Coculture potency assays screen TIL samples before full expansion, cutting time and cost while improving cell therapy selection.

A cell-based assay measures anti-Clever-1 potency by tracking acLDL uptake inhibition, improving variant differentiation and stability testing.

Parallel microwells and controlled delivery channels let 3D organoids mimic tumor microenvironments for higher-throughput therapeutic screening.

PTK7 and GPC coreceptors are identified as CCN2 signaling targets, enabling agents that block complex formation in fibrosis and cancer.

Quantifying EDIL3 with primers, probes, and antibodies helps detect early APOE4-linked synaptic dysfunction and guide Alzheimer's treatment.

Using the same drug on both electrodes, this patch improves iontophoretic skin permeation and avoids wasted electrode area.

Optical readout from reflective micropillars captures cell force and stiffness to rapidly distinguish drug-resistant cells for precision screening.

Optical tracking of magnetic micropillar bending enables non-invasive, real-time cell force and hardness measurement at high throughput.

Microcolumn deformation converts cell force and hardness into optical signals for real-time, high-throughput typing without labels or phototoxicity.

Screens compounds by DEAD-box RNA helicase binding, p62 interaction, and droplet formation to speed selective autophagy tag discovery.

Micropillars with reflective and magnetic layers enable low-cost, real-time fluid sensing in microchannels with less flow disturbance.

By disrupting AANAT to lower melatonin, this mouse model reproduces accelerated healthy aging and neurodegeneration without disease-driven phenotypes.

Immobilized reporter proteins enable simultaneous ubiquitin, SUMO, and NEDD8 activity measurement from cell extracts.

A chimeric human-mouse BAFF gene improves human lymphocyte activation and survival in vivo for autoimmune therapeutic testing.

Cyclic peptides bind EGFR extracellularly to drive endocytosis and lysosomal degradation, helping overcome resistance in KRAS-mutant cancers.

Mass spectrometry-trained AI improves HLA class II epitope prediction by modeling presentation rules, allele specificity, and CD4+ T cell targets.

Using LY2157299 in a defined serum-free medium increases neural stem cell and brain organoid yield while removing animal-derived culture components.